{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:43:32Z","timestamp":1792658612505,"version":"4.5.0"},"reference-count":96,"publisher":"Centers for Disease Control MMWR Office","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MMWR Recomm. Rep."],"DOI":"10.15585\/mmwr.rr6903a1","type":"journal-article","created":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T15:22:56Z","timestamp":1587655376000},"page":"1-12","source":"Crossref","is-referenced-by-count":82,"title":["Preexposure Prophylaxis for Prevention of HIV Acquisition Among Adolescents: Clinical Considerations, 2020"],"prefix":"10.15585","volume":"69","author":[{"given":"Mary R.","family":"Tanner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Miele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila Salvant","family":"Valentine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Dunville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bill G.","family":"Kapogiannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn K.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6224","published-online":{"date-parts":[[2020,4,24]]},"reference":[{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R1","unstructured":"CDC. Preexposure prophylaxis for the prevention of HIV infection in the United States\u20142017 update: a clinical practice guideline. Atlanta, GA: US Department of Health and Human Services, CDC; 2018. https:\/\/www.cdc.gov\/hiv\/pdf\/risk\/prep\/cdc-hiv-prep-guidelines-2017.pdf"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R2","unstructured":"Gilead Sciences Inc. U.S. Food and Drug Administration approves expanded indication for Truvada (emtricitabine and tenofovir disoproxil fumarate) for reducing the risk of acquiring HIV-1 in adolescents [Press release]. Foster City, CA: Gilead Sciences Inc.; 2018. https:\/\/www.gilead.com\/news-and-press\/press-room\/press-releases\/2018\/5\/us-food-and-drug-administration-approves-expanded-indication-for-truvada-emtricitabine-and-tenofovir-disoproxil-fumarate-for-reducing-the-risk-of-"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R3","unstructured":"Descovy (emtricitabine and tenofovir alafenamide) [Package insert]. Foster City, CA: Gilead Sciences Inc.; 2019. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/208215s011lbl.pdf"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R4","unstructured":"CDC. HIV surveillance report, 2018 (preliminary); vol. 30. Atlanta, GA: US Department of Health and Human Services, CDC; 2019. https:\/\/www.cdc.gov\/hiv\/library\/reports\/hiv-surveillance.html"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R5","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1097\/QAI.0000000000000933","article-title":"Incidence of HIV infection and sexually transmitted infections and related risk factors among very young men who have sex with men.","volume":"72","author":"Garofalo","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R6","doi-asserted-by":"publisher","first-page":"S284","DOI":"10.2105\/AJPH.2018.304471","article-title":"Potential impact of HIV preexposure prophylaxis among black and white adolescent sexual minority males.","volume":"108","author":"Hamilton","year":"2018","journal-title":"Am J Public Health"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R7","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1093\/infdis\/jiw223","article-title":"Impact of the Centers for Disease Control\u2019s HIV preexposure prophylaxis guidelines for men who have sex with men in the United States.","volume":"214","author":"Jenness","year":"2016","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R8","first-page":"21","article-title":"Young HIV-infected adults are at greater risk for medication nonadherence.","volume":"4","author":"Becker","year":"2002","journal-title":"MedGenMed"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R9","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1001\/archpedi.159.8.764","article-title":"Longitudinal antiretroviral adherence among adolescents infected with human immunodeficiency virus.","volume":"159","author":"Murphy","year":"2005","journal-title":"Arch Pediatr Adolesc Med"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R10","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/QAI.0B013E31822D7564","article-title":"Clinical outcomes of adolescents and young adults in adult HIV care.","volume":"58","author":"Ryscavage","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R11","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1089\/aid.2006.0290","article-title":"Long-term observation of adolescents initiating HAART therapy: three-year follow-up.","volume":"23","author":"Flynn","year":"2007","journal-title":"AIDS Res Hum Retroviruses"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R12","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1089\/apc.2013.0345","article-title":"The adolescent and young adult HIV cascade of care in the United States: exaggerated health disparities.","volume":"28","author":"Zanoni","year":"2014","journal-title":"AIDS Patient Care STDs"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R13","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1097\/00002030-200106150-00015","article-title":"Non-adherence to highly active antiretroviral therapy predicts progression to AIDS.","volume":"15","author":"Bangsberg","year":"2001","journal-title":"AIDS"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R14","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1080\/09540120500101658","article-title":"Nonadherence to medical appointments is associated with increased plasma HIV RNA and decreased CD4 cell counts in a community-based HIV primary care clinic.","volume":"17","author":"Berg","year":"2005","journal-title":"AIDS Care"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R15","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1086\/427192","article-title":"Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy.","volume":"191","author":"Harrigan","year":"2005","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R16","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s11904-007-0010-0","article-title":"Adherence-resistance relationships to combination HIV antiretroviral therapy.","volume":"4","author":"Bangsberg","year":"2007","journal-title":"Curr HIV\/AIDS Rep"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R17","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1086\/512088","article-title":"High rates of forward transmission events after acute\/early HIV-1 infection.","volume":"195","author":"Brenner","year":"2007","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R18","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1146\/annurev.med.050108.151127","article-title":"Growing up with HIV: children, adolescents, and young adults with perinatally acquired HIV infection.","volume":"61","author":"Hazra","year":"2010","journal-title":"Annu Rev Med"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R19","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s10508-019-1429-2","article-title":"PrEP awareness, uptake, barriers, and correlates among adolescents assigned male at birth who have sex with males in the U.S.","volume":"49","author":"Macapagal","year":"2020","journal-title":"Arch Sex Behav"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R20","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.jadohealth.2018.03.016","article-title":"Adolescent health providers\u2019 willingness to prescribe pre-exposure prophylaxis (PrEP) to youth at risk of HIV infection in the United States.","volume":"63","author":"Hart-Cooper","year":"2018","journal-title":"J Adolesc Health"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R21","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1001\/jama.2018.1917","article-title":"HIV preexposure prophylaxis: a review.","volume":"319","author":"Riddell","year":"2018","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R22","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1542\/pir.29-5-161","article-title":"Adolescent psychological development: a review.","volume":"29","author":"Hazen","year":"2008","journal-title":"Pediatr Rev"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R23","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/dev.20442","article-title":"Adolescent risk taking, impulsivity, and brain development: implications for prevention.","volume":"52","author":"Romer","year":"2010","journal-title":"Dev Psychobiol"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R24","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1016\/j.jadohealth.2012.05.006","article-title":"Adolescent neurodevelopment.","volume":"52","author":"Spear","year":"2013","journal-title":"J Adolesc Health"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R25","unstructured":"Gill K, Dietrich J, Gray G, PlusPills: an open label, safety and feasibility study of oral pre-exposure prophylaxis (PrEP) in 15\u201319 year old adolescents in two sites in South Africa [Abstract]. Presented at the 9th IAS Conference on HIV Science, Paris, France; July 23\u201326, 2017."},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R26","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1001\/jamapediatrics.2017.2007","article-title":"Safety and feasibility of antiretroviral preexposure prophylaxis for adolescent men who have sex with men aged 15 to 17 years in the United States.","volume":"171","author":"Hosek","year":"2017","journal-title":"JAMA Pediatr"},{"key":"#cr-split#-key-10.15585\/mmwr.rr6903a1-202004231122-R27.1","unstructured":"Magnuson D, Hawkins T, Mera R. Adolescent use of Truvada (FTC\/TDF) for HIV pre-exposure prophylaxis (PrEP) in the United States (2012-2017) [Abstract]. Presented at AIDS 2018: 22nd International AIDS Conference, Amsterdam, Netherlands"},{"key":"#cr-split#-key-10.15585\/mmwr.rr6903a1-202004231122-R27.2","unstructured":"July 23-27, 2018. http:\/\/www.natap.org\/2018\/IAC\/IAC_35.htm"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R28","doi-asserted-by":"publisher","first-page":"3637","DOI":"10.1007\/s10461-018-2122-5","article-title":"Threefold increase in PrEP uptake over time with high adherence among young men who have sex with men in Chicago.","volume":"22","author":"Morgan","year":"2018","journal-title":"AIDS Behav"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R29","unstructured":"Truvada (emtricitabine\/tenofovir disoproxil fumarate) [Package insert]. Foster City, CA: Gilead Sciences Inc.; 2018. https:\/\/www.gilead.com\/~\/media\/Files\/pdfs\/medicines\/hiv\/truvada\/truvada_pi.PDF"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R30","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/MOP.0000000000000512","article-title":"HIV preexposure prophylaxis for adolescents and young adults.","volume":"29","author":"Allen","year":"2017","journal-title":"Curr Opin Pediatr"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R31","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1056\/NEJMoa1108524","article-title":"Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.","volume":"367","author":"Baeten","year":"2012","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R32","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","article-title":"Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.","volume":"363","author":"Grant","year":"2010","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R33","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1097\/QAI.0000000000001475","article-title":"Brief report: recovery of bone mineral density after discontinuation of tenofovir-based HIV pre-exposure prophylaxis.","volume":"76","author":"Glidden","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R34","doi-asserted-by":"publisher","first-page":"e90111","DOI":"10.1371\/journal.pone.0090111","article-title":"Bone mineral density changes among HIV-uninfected young adults in a randomised trial of pre-exposure prophylaxis with tenofovir-emtricitabine or placebo in Botswana.","volume":"9","author":"Kasonde","year":"2014","journal-title":"PLoS One"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R35","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/QAI.0000000000001179","article-title":"An HIV preexposure prophylaxis demonstration project and safety study for young MSM.","volume":"74","author":"Hosek","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R36","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/cid\/ciz486","article-title":"Changes in bone mass after discontinuation of preexposure prophylaxis (PrEP) with tenofovir disoproxil fumarate\/emtricitabine in young men who have sex with men: extension phase results of adolescent trials network protocols 110 and 113.","volume":"70","author":"Havens","year":"2020","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R37","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1089\/aid.2018.0096","article-title":"Short communication: association of vitamin D insufficiency and protective tenofovir diphosphate concentrations with bone toxicity in adolescent boys and young men using tenofovir disoproxil fumarate\/emtricitabine for HIV pre-exposure prophylaxis.","volume":"35","author":"Havens","year":"2019","journal-title":"AIDS Res Hum Retroviruses"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R38","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S2055-6640(20)30312-5","article-title":"How safe is TDF\/FTC as PrEP? A systematic review and meta-analysis of the risk of adverse events in 13 randomised trials of PrEP.","volume":"4","author":"Pilkington","year":"2018","journal-title":"J Virus Erad"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R39","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1097\/INF.0000000000000649","article-title":"Long-term efficacy and safety of tenofovir disoproxil fumarate in HIV-1-infected adolescents failing antiretroviral therapy: the final results of study GS-US-104-0321.","volume":"34","author":"Della Negra","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R40","doi-asserted-by":"publisher","first-page":"e827","DOI":"10.1542\/peds.2006-3078","article-title":"Long-term safety and efficacy results of once-daily emtricitabine-based highly active antiretroviral therapy regimens in human immunodeficiency virus-infected pediatric subjects.","volume":"121","author":"Saez-Llorens","year":"2008","journal-title":"Pediatrics"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R41","unstructured":"Emtriva (emtricitabine) [Package insert]. Foster City, CA: Gilead Sciences Inc.; 2017. https:\/\/www.gilead.com\/~\/media\/Files\/pdfs\/medicines\/hiv\/emtriva\/emtriva_pi.pdf"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R42","unstructured":"US Food and Drug Administration. FDA briefing document: meeting of the Antimicrobial Drugs Advisory Committee. Silver Spring, MD: US Food and Drug Administration; 2019. https:\/\/www.fda.gov\/media\/129607\/download"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R43","unstructured":"CDC. Minors\u2019 consent laws for HIV and STI services. Atlanta, GA: US Department of Health and Human Services, CDC; 2018. https:\/\/www.cdc.gov\/hiv\/policies\/law\/states\/minors.html"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R44","doi-asserted-by":"publisher","first-page":"e20172858","DOI":"10.1542\/peds.2017-2858","article-title":"Sexual and reproductive health care services in the pediatric setting.","volume":"140","author":"Marcell","year":"2017","journal-title":"Pediatrics"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R45","unstructured":"US Department of Health and Human Services [Internet]. HIV prevention in family planning. Washington, DC: US Department of Health and Human Services, Office of Population Affairs; 2018. https:\/\/www.hhs.gov\/opa\/title-x-family-planning\/preventive-services\/hiv-prevention\/index.html"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R46","doi-asserted-by":"publisher","first-page":"S119","DOI":"10.1016\/j.amepre.2012.09.044","article-title":"State adolescent consent laws and implications for HIV pre-exposure prophylaxis.","volume":"44","author":"Culp","year":"2013","journal-title":"Am J Prev Med"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R47","first-page":"295","article-title":"PrEP and our youth: implications in law and policy.","volume":"30","author":"Burda","year":"2016","journal-title":"Columbia J Gend Law"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R48","unstructured":"Todres J. Can mandatory reporting laws help child survivors of human trafficking? Madison, WI: University of Wisconsin, Wisconsin Law Review Forward; 2016. https:\/\/wlr.law.wisc.edu\/"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R49","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.jadohealth.2011.08.005","article-title":"Forging partnerships with parents while delivering adolescent confidential health services: a clinical paradox.","volume":"49","author":"Tebb","year":"2011","journal-title":"J Adolesc Health"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R50","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.jadohealth.2016.06.011","article-title":"The longitudinal impact of perceptions of parental monitoring on adolescent initiation of sexual activity.","volume":"59","author":"Ethier","year":"2016","journal-title":"J Adolesc Health"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R51","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jadohealth.2012.06.013","article-title":"Parental acceptability of contraceptive methods offered to their teen during a confidential health care visit.","volume":"52","author":"Hartman","year":"2013","journal-title":"J Adolesc Health"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R52","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jadohealth.2013.08.009","article-title":"Self-reported barriers to medication adherence among chronically ill adolescents: a systematic review.","volume":"54","author":"Hangh\u00f8j","year":"2014","journal-title":"J Adolesc Health"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R53","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1097\/QAI.0000000000001837","article-title":"Brief report: HIV pre-exposure prophylaxis engagement among adolescent men who have sex with men: the role of parent-adolescent communication about sex.","volume":"79","author":"Thoma","year":"2018","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R54","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.jadohealth.2017.06.003","article-title":"The use of medication by adolescents and young adults.","volume":"61","author":"Society for Adolescent Health and Medicine","year":"2017","journal-title":"J Adolesc Health"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R55","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jadohealth.2010.10.004","article-title":"Partnerships between parents and health care professionals to improve adolescent health.","volume":"49","author":"Ford","year":"2011","journal-title":"J Adolesc Health"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R56","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.jadohealth.2016.03.001","article-title":"Parent and adolescent interest in receiving adolescent health communication information from primary care clinicians.","volume":"59","author":"Ford","year":"2016","journal-title":"J Adolesc Health"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R57","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.jadohealth.2011.02.006","article-title":"Confidentiality with adolescents in the medical setting: what do parents think?","volume":"49","author":"Duncan","year":"2011","journal-title":"J Adolesc Health"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R58","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/S1054-139X(03)00394-X","article-title":"Attitudinal and contextual factors associated with discussion of sexual issues during adolescent health visits.","volume":"35","author":"Merzel","year":"2004","journal-title":"J Adolesc Health"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R59","doi-asserted-by":"publisher","first-page":"e20170254","DOI":"10.1542\/peds.2017-0254","article-title":"2017 recommendations for preventive pediatric health care.","volume":"139","author":"Committee on Practice and Ambulatory Medicine","year":"2017","journal-title":"Pediatrics"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R60","doi-asserted-by":"publisher","first-page":"3417","DOI":"10.1007\/s10461-018-2081-x","article-title":"Patient-provider communication barriers and facilitators to HIV and STI preventive services for adolescent MSM.","volume":"22","author":"Fisher","year":"2018","journal-title":"AIDS Behav"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R61","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.jadohealth.2018.07.021","article-title":"HIV pre-exposure prophylaxis medication for adolescents and young adults: a position paper of the Society for Adolescent Health and Medicine.","volume":"63","author":"Society for Adolescent Health and Medicine","year":"2018","journal-title":"J Adolesc Health"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R62","first-page":"64","article-title":"Getting into adolescent heads: an essential update.","volume":"21","author":"Goldenring","year":"2004","journal-title":"Contemp Pediatr"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R63","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/0197-0070(91)90084-Y","article-title":"HEADSS, a psychosocial risk assessment instrument: implications for designing effective intervention programs for runaway youth.","volume":"12","author":"Cohen","year":"1991","journal-title":"J Adolesc Health"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R64","article-title":"Sexually transmitted diseases treatment guidelines, 2015.","volume":"64","author":"Workowski","year":"2015","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R65","unstructured":"US Department of Health and Human Services, Office of Minority Health [Internet]. Think cultural health: a physician\u2019s practical guide to culturally competent care. Washington, DC: US Department of Health and Human Services, Office of Minority Health; 2018. https:\/\/cccm.thinkculturalhealth.hhs.gov\/default.asp"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R66","unstructured":"AIDS Education and Training Center Program, National Coordinating Resource Center [Internet]. Cultural competency curriculum. Newark, NJ: Rutgers University School of Nursing; 2017. https:\/\/aidsetc.org\/resource\/cultural-competency-curriculum"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R67","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1542\/peds.2008-0694","article-title":"Achieving quality health services for adolescents.","volume":"121","author":"Committee on Adolescence American Academy of Pediatrics","year":"2008","journal-title":"Pediatrics"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R68","doi-asserted-by":"publisher","first-page":"894","DOI":"10.7326\/M14-1965","article-title":"Behavioral counseling interventions to prevent sexually transmitted infections: U.S. Preventive Services Task Force recommendation statement.","volume":"161","author":"LeFevre","year":"2014","journal-title":"Ann Intern Med"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R69","doi-asserted-by":"publisher","first-page":"e25399","DOI":"10.1002\/jia2.25399","article-title":"Lack of health insurance is associated with delays in PrEP initiation among young black men who have sex with men in Atlanta, US: a longitudinal cohort study.","volume":"22","author":"Serota","year":"2019","journal-title":"J Int AIDS Soc"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R70","unstructured":"US Department of Health and Human Services. Ready, Set, PrEP expands access to medication to prevent HIV [Press release]. Washington, DC: US Department of Health and Human Services; 2019. https:\/\/www.hhs.gov\/about\/news\/2019\/12\/03\/ready-set-prep-expands-access-to-medication-to-prevent-hiv.html"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R71","unstructured":"Ready, Set, PrEP [Internet]. Washington, DC: US Department of Health and Human Services; 2020. https:\/\/www.getyourprep.com\/"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R72","unstructured":"CDC. Pre-exposure prophylaxis (PrEP) [Internet]. Atlanta, GA: US Department of Health and Human Services, CDC; 2019. https:\/\/www.cdc.gov\/hiv\/risk\/prep\/index.html"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R73","unstructured":"CDC. Paying for PrEP [Internet]. Atlanta, GA: US Department of Health and Human Services, CDC; 2019. https:\/\/www.cdc.gov\/hiv\/pdf\/risk\/prep\/cdc-hiv-PayingforPrEP-flyer.pdf"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R74","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1056\/NEJMoa1402269","article-title":"Tenofovir-based preexposure prophylaxis for HIV infection among African women.","volume":"372","author":"Marrazzo","year":"2015","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R75","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1202614","article-title":"Preexposure prophylaxis for HIV infection among African women.","volume":"367","author":"Van Damme","year":"2012","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R76","doi-asserted-by":"publisher","first-page":"151ra125","DOI":"10.1126\/scitranslmed.3004006","article-title":"Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men.","volume":"4","author":"Anderson","year":"2012","journal-title":"Sci Transl Med"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R77","doi-asserted-by":"publisher","first-page":"e83736","DOI":"10.1371\/journal.pone.0083736","article-title":"Strong relationship between oral dose and tenofovir hair levels in a randomized trial: hair as a potential adherence measure for pre-exposure prophylaxis (PrEP).","volume":"9","author":"Liu","year":"2014","journal-title":"PLoS One"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R78","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1007\/s10461-013-0661-3","article-title":"The use of cell phone support for non-adherent HIV-infected youth and young adults: an initial randomized and controlled intervention trial.","volume":"18","author":"Belzer","year":"2014","journal-title":"AIDS Behav"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R79","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1007\/s10461-015-1192-x","article-title":"A randomized controlled trial of personalized text message reminders to promote medication adherence among HIV-positive adolescents and young adults.","volume":"20","author":"Garofalo","year":"2016","journal-title":"AIDS Behav"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R80","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/COH.0000000000000220","article-title":"Current concepts for PrEP adherence in the PrEP revolution: from clinical trials to routine practice.","volume":"11","author":"Haberer","year":"2016","journal-title":"Curr Opin HIV AIDS"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R81","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1007\/s10461-012-0182-5","article-title":"Supporting study product use and accuracy in self-report in the iPrEx study: next step counseling and neutral assessment.","volume":"16","author":"Amico","year":"2012","journal-title":"AIDS Behav"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R82","unstructured":"US National Library of Medicine. Pre-exposure prophylaxis (PrEP) adherence enhancement guided by iTAB and drug levels for women (AEGiS) [Internet]. Bethesda, MD: National Library of Medicine; 2019. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02584140"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R83","unstructured":"US National Library of Medicine. Evaluating the pharmacokinetics, feasibility, acceptability, and safety of oral pre-exposure prophylaxis for HIV prevention during pregnancy and postpartum [Internet]. Bethesda, MD: National Library of Medicine; 2019. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03386578"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R84","unstructured":"US National Library of Medicine. PrEP and HIV Therapy (TARGET) [Internet]. Bethesda, MD: US National Library of Medicine; 2018. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03012607"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R85","unstructured":"US National Library of Medicine. Validation of a urine assay to measure tenofovir levels in patients taking tenofovir alafenamide [Internet]. Bethesda, MD: US National Library of Medicine; 2018. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03350672"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R86","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1089\/apc.2014.0273","article-title":"Clinician attitudes toward CDC interim pre-exposure prophylaxis (PrEP) guidance and operationalizing PrEP for adolescents.","volume":"29","author":"Mullins","year":"2015","journal-title":"AIDS Patient Care STDS"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R87","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr6504a1","article-title":"U.S. selected practice recommendations for contraceptive use, 2016.","volume":"65","author":"Curtis","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R88","unstructured":"The Adolescent Medicine Trials Network for HIV\/AIDS Interventions [Internet]. Current studies. Chapel Hill, NC: University of North Carolina at Chapel Hill, Collaborative Studies Coordinating Center; 2018. https:\/\/atnweb.org\/atnweb\/studies"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R89","unstructured":"US National Library of Medicine. LYNX: a novel mobile app to support linkage to HIV\/STI testing PrEP for young men who have sex with men [Internet]. Bethesda, MD: US National Library of Medicine; 2019. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03177512"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R90","unstructured":"US National Library of Medicine. P3 (Prepared, Protected, emPowered) (P3) [Internet]. Bethesda, MD: US National Library of Medicine; 2019. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03320512"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R91","unstructured":"US National Library of Medicine. Get Connected efficacy trial [Internet]. Bethesda, MD: US National Library of Medicine; 2019. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03132415"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R92","unstructured":"US National Library of Medicine. Mobile-based application \u201cMyChoices\u201d [Internet]. Bethesda, MD: US National Library of Medicine; 2018. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03179319"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R93","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1097\/QAI.0000000000001901","article-title":"Brief report: role of sociobehavioral factors in subprotective TFV-DP levels among YMSM enrolled in 2 PrEP trials.","volume":"80","author":"Arrington-Sanders","year":"2019","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R94","doi-asserted-by":"publisher","first-page":"3645","DOI":"10.1007\/s10461-018-2125-2","article-title":"High rate of discontinuation may diminish PrEP coverage among young men who have sex with men.","volume":"22","author":"Morgan","year":"2018","journal-title":"AIDS Behav"},{"key":"key-10.15585\/mmwr.rr6903a1-202004231122-R95","unstructured":"Clinician Consultation Center [Internet]. PrEP: pre-exposure prophylaxis. San Francisco, CA: University of California San Francisco, Clinician Consultation Center; 2018. http:\/\/nccc.ucsf.edu\/clinician-consultation\/prep-pre-exposure-prophylaxis\/"}],"container-title":["MMWR. Recommendations and Reports"],"original-title":[],"deposited":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T16:26:36Z","timestamp":1615393596000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cdc.gov\/mmwr\/volumes\/69\/rr\/rr6903a1.htm?s_cid=rr6903a1_w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,24]]},"references-count":96,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,4,24]]}},"URL":"https:\/\/doi.org\/10.15585\/mmwr.rr6903a1","relation":{},"ISSN":["1057-5987","1545-8601"],"issn-type":[{"value":"1057-5987","type":"print"},{"value":"1545-8601","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,4,24]]},"published":{"date-parts":[[2020,4,24]]}}}